Implications of the Revised Criteria for Diagnosis and Classification of Diabetes Mellitus (Editorial) Implications of the Revised Criteria for Diagnosis and Classification of Diabetes Mellitus (Editorial)

Implications of the Revised Criteria for Diagnosis and Classification of Diabetes Mellitus (Editorial‪)‬

Clinical Chemistry 1997, Dec, 43, 12

    • €2.99
    • €2.99

Publisher Description

Diabetes mellitus is a heterogeneous disease. It comprises several distinct pathophysiologic disorders of carbohydrate metabolism, each of which ultimately manifests with hyperglycemia. Although the prevalence of the disease is unknown, 13 million people are estimated to have diabetes in the US [1]. The severe complications (renal, retinal, and cardiovascular) associated with the disease contribute to the $92 000 000 000 in annual healthcare costs in the US (1992 estimate) [2]. Therefore, the recent Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus that recommends new classification and diagnostic criteria for diabetes [3] merits contemplation. Since the advent of blood glucose assays, the exclusive criterion for the diagnosis of diabetes has been hyperglycemia, either fasting or postprandial. For many years diabetes was diagnosed by the oral glucose tolerance test (OGTT), the cutoff having been established as 2SD above the mean of the glucose concentrations in healthy volunteers. In 1975 Siperstein estimated that more than half the population older than 60 years was abnormal by these criteria [4]. However, those values had more statistical than clinical significance, as follow-up for 10 years revealed that a substantial proportion of these individuals did not develop diabetes and many returned to normal glucose tolerance. Moreover, there was considerable variability among diabetologists in the diagnostic criteria used in practice [5]. To resolve these issues, in 1979 the National Diabetes Data Group [6] proposed criteria that were based on the bimodal distribution of blood glucose concentrations in populations with a high prevalence of diabetes, such as Pima Indians and Nauruans. Optimal separation between nondiabetic and diabetic subjects in these groups is at 11.1 mmol/L (200 mg/dL, 2000 mg/L) 2 h after an oral glucose load and at 7.8 mmol/L (140 mg/dL) for fasting plasma glucose (FPG). Thus, the diagnostic criteria were (a) classic symptoms of diabetes with unequivocal increase of plasma glucose, (b) FPG [greater than or equal to]11.1 mmol/L, or (c) a 2-h (and one other) postload value [greater than or equal to]11.1 mmol/L during an OGTT [6].

GENRE
Science & Nature
RELEASED
1997
1 December
LANGUAGE
EN
English
LENGTH
10
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
175.3
KB
A Rosetta Stone for Insulin Treatment: Self-Monitoring of Blood Glucose (Editorial) A Rosetta Stone for Insulin Treatment: Self-Monitoring of Blood Glucose (Editorial)
2004
Type 2 Diabetes: An Overview (Beckman Conference) (Clinical Report) Type 2 Diabetes: An Overview (Beckman Conference) (Clinical Report)
1999
The Metabolic Syndrome: Requiescat in Pace. The Metabolic Syndrome: Requiescat in Pace.
2005
Role of GGT in Diagnosis of Metabolic Syndrome: A Clinic-Based Cross-Sectional Survey (Gamma-Glutamyl Transferase) (Report) Role of GGT in Diagnosis of Metabolic Syndrome: A Clinic-Based Cross-Sectional Survey (Gamma-Glutamyl Transferase) (Report)
2010
Effects of Resistance Training on Metabolic Profile of Adults with Type 2 Diabetes. Effects of Resistance Training on Metabolic Profile of Adults with Type 2 Diabetes.
2009
Clinical Trial of Cecropia Obtusifolia and Marrubium Vulgare Leaf Extracts on Blood Glucose and Serum Lipids in Type 2 Diabetics. Clinical Trial of Cecropia Obtusifolia and Marrubium Vulgare Leaf Extracts on Blood Glucose and Serum Lipids in Type 2 Diabetics.
2004
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003